Deinove - Termination of coverage
Edison Investment Research is terminating coverage on Augean (AUG), Deinove (ALDEI), Photocure (PHO), RADA Electronic Industries (RADA) and Ryvu...
634 Views
Deinove - Phase II study with DNV3837 for C. diff starts
Deinove reported that the first patient has been enrolled in its Phase II study with a novel quinolonyl-oxazolidinone class antibiotic DNV3837 for...
602 Views
Deinove - Steady progress on all fronts
Deinove released its H119 results on 26 September 2019. The company reported progress with most of its projects in the pipeline, which is well...
1.1k Views
Cash conservation and operational progress
A refocused business, a strengthened management team and progress with its underlying research programmes suggest Deinove is on course to generate...
95 Views
Implementing the new strategy
Deinove has selected key markets of interest, identified strains from its library of bacteria, which indicate suitability for commercial...
50 Views
No more insights